Inaugural case performed by spine surgeon Dr. Scott L. Parker highlights the system's strength, versatility, and precision for supporting multi-level spinal constructs
A Digital Publication for the Practicing Medical Specialist, Industry Executive and Investor
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of the trends, innovations, and breakthroughs shaping the future of medical technology.
We also strive to provide a distinctive perspective on the rapidly evolving healthcare landscape. By staying connected with our reporting, you gain access to exclusive insights on industry developments, emerging technologies, and global regulatory changes that influence the medical device sector. At the same time, you join a vibrant community of professionals, innovators, and thought leaders dedicated to advancing healthcare through cutting‑edge solutions.
We invite you to explore our wide range of content—from the latest product announcements to detailed analyses of industry trends. And if our mission aligns with your goals, we offer opportunities for advertising and collaboration, helping you connect with a highly engaged audience of medical technology professionals.
Definition medical devices.
Inaugural case performed by spine surgeon Dr. Scott L. Parker highlights the system's strength, versatility, and precision for supporting multi-level spinal constructs
Quadessy delivers multi-layer skin remodeling through a unique tip and dual-depth design
Medtronic's latest partnership with Merit Medical Systems introduces the groundbreaking ViaVerte™ BVNA system—an innovative solution for chronic vertebrogenic pain
First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD
The study, published in The March 2026 edition of Federal Practitioner, reported an association between thermal therapy use and reduced opioid and benzodiazepine utilization, as well as lower healthcare utilization in the patient population.
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including slower functional decline, reduced risk of ALS-related complications, and modulation of disease-relevant biomarkers
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients
Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
Redipor® Legionella agar plate range - specifically designed to support the detection and enumeration of Legionella in water samples
Acquisition of new generation extended-dwell catheter and patented insertion system strengthens Vygon’s vascular access leadership and accelerates US expansion
Acquisition to expand Boston Scientific’s cardiovascular portfolio and further address increasing prevalence of vascular diseases
PathoQuest was built and supported by Kurma Partners and the Pasteur Institute and based on the groundbreaking work of Prof. Marc Eloit
Philips offers one of the most comprehensive image-guided therapy portfolios in the industry, providing solutions for visual guidance during minimally invasive procedures and image-guided therapy devices designed to enhance procedural efficiency and improve patient outcomes
The financing significantly strengthens the company’s capital position as it expands U.S. commercial infrastructure and advances clinical evidence generation across its endovascular catheter platform.
Investments support seniors, people with disabilities, family caregivers, and the direct care workforce statewide

By Ravi Pratap Maddimsetty, co-founder and CTO of Uniqode, responsible for all technology strategy, product innovation and engineering execution

In this ever-changing healthcare landscape, prioritizing data-driven decision-making and proactively adopting advanced technologies will position health systems to achieve lasting success in 2026 and the years ahead

Laboratories face mounting pressure to modernize imaging, preserve tissue, and reduce sequencing failures as adoption continues to move at a glacial pace
Dr. Debra Barker, Chief Medical Officer, Centauri Therapeutics, said: “This designation from the FDA will be invaluable as we continue to advance toward first in-human trials for CTX-187. The recognition of the potential value of our technology further underpins our belief in its potential to transform treatment paradigms for Gram-negative bacterial infections, filling an urgently needed gap in the market for new and effective treatment options for clinically vulnerable patients.”
Designation may provide U.S. patients faster access to groundbreaking technology
“We are pleased to be able to bring Dr. Khan into our leadership team. He brings a strong blend of clinical, scientific, and strategic insight to SynerFuse® that will help us in our mission to provide relief to people afflicted with chronic low back and leg pain,” said SynerFuse® CEO and Founder Justin Zenanko.
Bioprocessing leader to drive continued commercial development and international expansion
The Supervisory Board will submit to the Annual General Meeting of Shareholders 2026 a proposal to appoint John DeFord (American, 1962) as a new member of the Supervisory Board.

CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day to support faster diagnosis by making scans available in near-real time

Co-funded by the EU’s Innovative Health Initiative (IHI), the Philips-coordinated research consortium will combine advanced medical imaging, robotic guidance technologies, and AI to standardize and enhance the precision of minimally invasive cancer treatments
Retrospective Analysis of Over 120,000 Echocardiographic Studies Provides Clinical Evidence of Diagnostic Accuracy for Heart Failure and Valvular Disease

The new suite brings advanced treatment options to pediatric patients with various types of strokes, including blood vessel malformations causing bleeding in the brain, as well as blood clots

Good Sam and Dr. Jue are the only hospital and surgeon from Orlando through Miami to perform the surgery

The advanced transcatheter intervention was undertaken to treat a repeatedly failing heart valve in a patient with a long and challenging history of aortic valve disease
The new award provides up to $70,000 in funding to a Fellow-in-Training or an early-career cardiologist
Pilot program addresses critical evidence gap in emerging regenerative medicine treatments for 32.5 million Americans with knee osteoarthritis
Recommended employer actions include need for disruption, heightened scrutiny of vendor partners, sharper focus on preventive care and chronic condition management
Health information exchange and healthcare interoperability are related but not interchangeable. One focuses on moving data across boundaries. The other ensures that data can be used meaningfully inside systems.
The Magic of Automation: How Carton Packaging Machines Transform Production Lines
Unleashing Speed: The Impact of Carton Packaging on Production Rates
The staffing challenges facing healthcare will not disappear

This article explains steps to take to solve our 2026 registered nurse shortage
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.